Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

QSI

Quantum-Si Incorporated

Feb 11 • 04:00PM ET

1.04

-0.06 -5.45 %

Healthcare • Medical Devices • USA • NASD

Peers: PACB BNGO BIO ILMN TWST CDNA NTRA TMO EXAS NTLA

| Held by: ARKG VTI IWM VXF IWN IBB VTWO VHT IWC ITOT

Index	RUT	P/E	-	EPS (ttm)	-0.66	Insider Own	20.03%	Shs Outstand	195.52M	Perf Week	0.97%
Market Cap	224.11M	Forward P/E	-	EPS next Y	-0.45	Insider Trans	-0.44%	Shs Float	172.33M	Perf Month	-14.05%
Enterprise Value	2.88M	PEG	-	EPS next Q	-0.12	Inst Own	30.24%	Short Float	10.94%	Perf Quarter	-34.80%
Income	-116.85M	P/S	70.47	EPS this Y	25.29%	Inst Trans	2.30%	Short Ratio	3.78	Perf Half Y	-10.34%
Sales	3.18M	P/B	0.95	EPS next Y	15.60%	ROA	-47.06%	Short Interest	18.86M	Perf YTD	-5.45%
Book/sh	1.09	P/C	0.99	EPS next 5Y	18.81%	ROE	-52.44%	52W High	3.10 -66.45%	Perf Year	-45.83%
Cash/sh	1.05	P/FCF	-	EPS past 3/5Y	16.08% 33.79%	ROIC	-49.11%	52W Low	0.92 12.46%	Perf 3Y	-51.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-82.91%	Volatility	9.69% 7.51%	Perf 5Y	-89.96%
Dividend TTM	-	EV/Sales	0.91	EPS Y/Y TTM	-4.07%	Oper. Margin	-3299.37%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.59	Sales Y/Y TTM	40.20%	Profit Margin	-3677.97%	RSI (14)	40.46	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	10.75	EPS Q/Q	3.94%	SMA20	-10.02%	Beta	3.00	Target Price	2.67
Payout	-	Debt/Eq	0.02	Sales Q/Q	-29.86%	SMA50	-15.35%	Rel Volume	0.81	Prev Close	1.10
Employees	149	LT Debt/Eq	0.01	Earnings	Nov 05 AMC	SMA200	-30.71%	Avg Volume	4.99M	Price	1.04
IPO	Nov 13, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-27.53% -7.89%	Trades		Volume	4,048,955	Change	-5.45%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-07-25	Initiated	Alliance Global Partners	Buy	$3.75
Dec-08-23	Initiated	H.C. Wainwright	Buy	$3
Sep-25-23	Downgrade	Canaccord Genuity	Buy → Hold	$3.50 → $2
Oct-20-21	Initiated	Canaccord Genuity	Buy	$13

Feb-10-26 08:00AM	Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 (Business Wire)
Feb-05-26 08:00AM	Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection (Business Wire) -9.50%
Jan-21-26 04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga) +6.50%
Dec-22-25 08:00AM	Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements (Business Wire)
Dec-15-25 06:00PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:00AM	Loading…
Nov-20-25 08:00AM	Quantum-Si Highlights Significant Development Advancements for Proteus and Industry Leading Technology Pipeline at Investor & Analyst Day (Business Wire)
Nov-19-25 08:00AM	Quantum-Si to Highlight Significant Proteus Platform Development Progress and Provide Insights into the Companys Industry Leading Technology Pipeline at Investor & Analyst Day (Business Wire)
Nov-06-25 12:05AM	Quantum-Si Inc (QSI) Q3 2025 Earnings Call Highlights: Innovation Milestones Amid Revenue Challenges (GuruFocus.com) -8.33%
Nov-05-25 07:50PM	Quantum-Si Incorporated (QSI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Quantum-Si Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-04-25 08:27AM	Earnings To Watch: Quantum-Si Inc (QSI) Reports Q3 2025 Result (GuruFocus.com) -8.00%
Oct-20-25 08:00AM	Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) +13.38%
Oct-14-25 08:25AM	Sono-Tek Corporation (SOTK) Q2 Earnings Beat Estimates (Zacks)
Oct-13-25 08:00AM	Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025 (Business Wire) +24.55%
Oct-10-25 04:35PM	Why Quantum-Si Stock Flopped on Friday (Motley Fool)
04:05PM	Loading…
Sep-15-25 04:05PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.78% +5.56%
Sep-08-25 08:00AM	Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing (Business Wire)
Aug-19-25 08:00AM	Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference (Business Wire) -5.50%
Aug-13-25 04:05PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-08-25 08:00AM	Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit (Business Wire)
Aug-07-25 11:58AM	Quantum-Si's Q2 Loss In Line With Estimates, Revenues Rise Y/Y (Zacks)
Aug-06-25 03:26AM	Quantum-Si Inc (QSI) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing New ... (GuruFocus.com)
Aug-05-25 06:45PM	Quantum-Si Incorporated (QSI) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Quantum-Si Reports Second Quarter 2025 Financial Results (Business Wire)
Aug-04-25 11:37AM	QSI Gears Up to Post Q2 Earnings: What's in Store for the Stock? (Zacks)
10:03AM	Earnings To Watch: Quantum-Si Inc (QSI) Reports Q2 2025 Result (GuruFocus.com)
Jul-21-25 08:00AM	Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Jul-14-25 08:00AM	Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025 (Business Wire)
Jul-04-25 10:45PM	Quantum-Si prices $50M registered direct offering of common stock at $1.67 (TipRanks)
Jul-03-25 08:34PM	Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock (Business Wire) +8.08% -14.72%
08:00AM	Loading…
Jun-24-25 08:00AM	Quantum-Si Platinum Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives (Business Wire) +13.94%
Jun-19-25 08:00AM	Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization (Business Wire)
Jun-17-25 08:00AM	Quantum-Si Customer to Showcase Protein Barcoding for Nucleic AcidLNP Therapeutic Development at Festival of Genomics Boston (Business Wire) -5.08%
Jun-13-25 04:05PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.26% +6.63%
Jun-10-25 08:00AM	Quantum-Sis Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay (Business Wire)
May-15-25 05:25PM	Quantum-Si Incorporated (QSI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Quantum-Si Reports First Quarter 2025 Financial Results (Business Wire)
May-13-25 05:45PM	QuickLogic (QUIK) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-12-25 08:00AM	Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Sis Next-Gen Protein Sequencing Platform in Upcoming Nature Webinar on May 15 (Business Wire) +19.84%
May-07-25 06:40PM	Silvaco Group, Inc. (SVCO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +10.83%
Apr-24-25 08:00AM	Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025 (Business Wire)
Mar-26-25 08:00AM	Quantum-Si Begins Shipping Platinum Pro, Advancing Accessibility in Next-Gen Protein Sequencing (Business Wire)
Mar-24-25 06:01AM	Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research (Business Wire)
Mar-20-25 08:00AM	Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research (Business Wire) -9.32%
Mar-17-25 11:09AM	Quantum computing, Affirm, Netflix upgrade: Market Minute (Yahoo Finance Video) +21.32%
Mar-13-25 04:05PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.00% +19.30%
Mar-03-25 04:05PM	Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire) -5.80% +6.15%
Feb-18-25 04:05PM	Quantum-Sis Customers and Researchers to Showcase Next-Generation Protein Sequencing at AGBT 2025 (Business Wire)
Feb-13-25 08:00AM	Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing at US HUPO 2025 (Business Wire)
Feb-12-25 08:00AM	Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 (Business Wire)
Feb-11-25 08:00AM	Preprint from Northwestern University Highlights Complementary Proteomic Analysis of Interleukin-6 Using Next-Generation Protein Sequencing and Mass Spectrometry (Business Wire)
Feb-04-25 08:00AM	Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies (Business Wire) +6.04%
Jan-28-25 08:00AM	Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus Instrument (Business Wire) -5.88%
Jan-20-25 08:00AM	Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK (Business Wire)
Jan-18-25 08:05AM	Quantum-Si announces inducement grants under Nasdaq listing rule (TipRanks)
Jan-17-25 08:00AM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -11.81%
Jan-13-25 08:00AM	Quantum-Si Launches Platinum Pro: The End-to-End Solution for Deeper Insights in Proteomics (Business Wire) -27.03%
Jan-08-25 08:00AM	Quantum-Sis New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics (Business Wire) -24.46%
Jan-03-25 04:06PM	Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock (Business Wire)
Dec-20-24 08:00AM	Quantum-Si's New Preprint Showcases Advances in Protein Variant Detection using ProteoVue Software with Next-Generation Protein Sequencing (Business Wire)
Dec-18-24 08:00AM	Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.57%
Dec-12-24 05:00AM	Quantum-Si Expands International Distribution Network (Business Wire) -5.73%
Dec-04-24 08:30AM	Quantum-Si Launches Platinum New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing (Business Wire) +10.71%
Dec-03-24 08:30AM	Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening (Business Wire)
Nov-21-24 06:00AM	Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor and Analyst Event (Business Wire) -12.95%
Nov-20-24 07:30AM	Avantor to Distribute Quantum-Sis Next-Generation Protein Sequencing Technology (Business Wire) +119.59%
07:00AM	Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA (Business Wire)
06:30AM	Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform (Business Wire)
06:00AM	Quantum-Si and Planet Innovation to Partner on Proteus (Business Wire)
Nov-18-24 04:01PM	Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -10.00%
Nov-13-24 06:00AM	Quantum-Si Honored with Frost & Sullivan's 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing (Business Wire)
Nov-12-24 07:30AM	Quantum-Si Reports Third Quarter 2024 Financial Results (Business Wire) -22.43%
Nov-07-24 04:01PM	University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Sis Next-Gen Protein Sequencer Platinum (Business Wire)
Nov-05-24 09:00AM	Quantum-Si to Participate in Upcoming Investment Conferences (Business Wire) +11.92%
Oct-31-24 03:35PM	Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 (Business Wire) -5.27%
Oct-30-24 06:00AM	Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting (Business Wire)
Oct-23-24 06:00AM	Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 (Business Wire)
Oct-17-24 05:21PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-10-24 06:00AM	Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024 (Business Wire)
Sep-24-24 06:00AM	Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing (Business Wire)
Sep-19-24 06:00AM	Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 (Business Wire) +6.00%
Sep-04-24 06:00AM	Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing Platform to Enhance Gene Therapy Development (Business Wire)
Aug-27-24 06:01PM	CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
04:30PM	Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
Aug-26-24 06:00AM	Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire) -5.94%
Aug-07-24 04:02PM	Quantum-Si Reports Second Quarter 2024 Financial Results (Business Wire) -5.91%
Jul-30-24 04:05PM	Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-17-24 04:05PM	Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire) -6.03%
Jul-09-24 03:56PM	3 Super-Cheap Penny Stocks for the Ultimate Speculator (InvestorPlace)
Jun-10-24 09:00AM	Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata (Business Wire)
May-31-24 08:00AM	Quantum-Si Announces Presentations at ASMS and ESHG (Business Wire)
May-30-24 04:05PM	Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors (Business Wire)
May-09-24 04:01PM	Quantum-Si Reports First Quarter 2024 Financial Results (Business Wire) -7.10%
Apr-30-24 08:30AM	Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time (Business Wire)
Apr-18-24 04:05PM	Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Mar-21-24 04:05PM	Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors (Business Wire) -5.79%
Mar-07-24 12:01PM	Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing on Platinum at US HUPO Conference (Business Wire) +29.81%
Feb-29-24 04:05PM	Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire) +10.78%
Feb-27-24 08:30AM	Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar (Business Wire) +5.36%

Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. It engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins in a massively parallel fashion. Its platform includes platinum NGPS instrument, platinum analysis software, and consumable kits for platinum instrument. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vieceli John S.	Chief Product Officer	Dec 22 '25	Sale	1.28	21,927	27,979	800,973	Dec 22 08:11 PM
Vieceli John S.	Officer	Dec 22 '25	Proposed Sale	1.28	21,927	27,979		Dec 22 08:05 PM
LaPointe Christian	GC & Corp. Secretary	Dec 22 '25	Sale	1.28	11,951	15,249	948,855	Dec 22 08:01 PM
LaPointe Christian	Officer	Dec 22 '25	Proposed Sale	1.28	11,951	15,249		Dec 22 07:53 PM
Keyes Jeffry R.	Chief Financial Officer	Dec 22 '25	Sale	1.28	8,627	11,008	1,163,197	Dec 22 07:50 PM
Keyes Jeffry R.	Officer	Dec 22 '25	Proposed Sale	1.28	8,627	11,008		Dec 22 07:38 PM
Hawkins Jeffrey Alan	President & CEO	Dec 22 '25	Sale	1.28	23,707	30,250	2,578,018	Dec 22 07:29 PM
Hawkins Jeffrey Alan	Officer	Dec 22 '25	Proposed Sale	1.28	23,707	30,250		Dec 22 07:19 PM
Vieceli John S.	Officer	Sep 22 '25	Proposed Sale	1.66	19,686	32,655		Oct 20 08:10 PM
LaPointe Christian	Officer	Sep 22 '25	Proposed Sale	1.66	10,728	17,796		Oct 20 08:09 PM
Keyes Jeffry R.	Officer	Sep 22 '25	Proposed Sale	1.66	7,746	12,847		Oct 20 08:07 PM
Hawkins Jeffrey Alan	Officer	Sep 22 '25	Proposed Sale	1.66	21,286	35,308		Oct 20 08:06 PM
Bennett Todd C.	Officer	Sep 22 '25	Proposed Sale	1.66	36,964	61,316		Oct 20 07:46 PM
ROTHBERG JONATHAN M	Director	Oct 16 '25	Sale	3.07	26,095	80,112	1,904,866	Oct 17 07:05 PM
ROTHBERG JONATHAN M	Director	Oct 16 '25	Proposed Sale	3.07	26,095	80,166		Oct 16 07:42 PM
LaPointe Christian	GC & Corp. Secretary	Sep 22 '25	Sale	1.68	5,364	9,025	966,170	Sep 24 06:31 PM
LaPointe Christian	GC & Corp. Secretary	Sep 23 '25	Sale	1.64	5,364	8,770	960,806	Sep 24 06:31 PM
Hawkins Jeffrey Alan	President & CEO	Sep 22 '25	Sale	1.68	10,643	17,908	2,612,368	Sep 24 06:31 PM
Hawkins Jeffrey Alan	President & CEO	Sep 23 '25	Sale	1.64	10,643	17,401	2,601,725	Sep 24 06:31 PM
Vieceli John S.	Chief Product Officer	Sep 22 '25	Sale	1.68	9,843	16,562	832,743	Sep 24 06:31 PM
Vieceli John S.	Chief Product Officer	Sep 23 '25	Sale	1.64	9,843	16,093	822,900	Sep 24 06:31 PM
Keyes Jeffry R.	Chief Financial Officer	Sep 22 '25	Sale	1.68	3,873	6,517	1,175,697	Sep 24 06:31 PM
Keyes Jeffry R.	Chief Financial Officer	Sep 23 '25	Sale	1.64	3,873	6,332	1,171,824	Sep 24 06:31 PM
Bennett Todd C.	Chief Commercial Officer	Sep 22 '25	Sale	1.68	18,482	31,098	700,003	Sep 24 06:31 PM
Bennett Todd C.	Chief Commercial Officer	Sep 23 '25	Sale	1.64	18,482	30,218	681,521	Sep 24 06:31 PM
Hawkins Jeffrey Alan	President & CEO	Jun 23 '25	Sale	1.61	23,705	38,257	2,623,011	Jun 24 07:14 PM
Vieceli John S.	Chief Product Officer	Jun 23 '25	Sale	1.61	21,923	35,382	842,586	Jun 24 07:11 PM
LaPointe Christian	GC & Corp. Secretary	Jun 23 '25	Sale	1.61	11,946	19,280	971,534	Jun 24 07:06 PM
Keyes Jeffry R.	Chief Financial Officer	Jun 23 '25	Sale	1.61	8,624	13,918	1,179,570	Jun 24 07:03 PM
Hawkins Jeffrey Alan	President & CEO	Mar 21 '25	Sale	1.39	23,707	32,846	2,646,716	Mar 24 06:48 PM
LaPointe Christian	General Counsel & Corp. Secr.	Mar 21 '25	Sale	1.39	4,896	6,783	983,480	Mar 24 06:42 PM
Keyes Jeffry R.	Chief Financial Officer	Mar 21 '25	Sale	1.39	8,626	11,951	1,188,194	Mar 24 06:34 PM
Vieceli John S.	Chief Product Officer	Mar 21 '25	Sale	1.39	4,317	5,981	864,509	Mar 24 06:11 PM

Open in Screener

TECH

Bio-Techne Corp

Feb 11 • 04:00PM ET

63.45

-1.35 -2.08 %

Healthcare • Biotechnology • USA • NASD

Peers: TMO DHR ILMN A BIO QGEN NEO MTD

| Held by: VTI VOO VB RSP IVV SPY VBK FBT XLV IBB

Index	S&P 500	P/E	123.42	EPS (ttm)	0.51	Insider Own	1.21%	Shs Outstand	155.88M	Perf Week	-7.60%
Market Cap	9.93B	Forward P/E	29.05	EPS next Y	2.18	Insider Trans	-1.77%	Shs Float	154.56M	Perf Month	-4.67%
Enterprise Value	10.10B	PEG	3.07	EPS next Q	0.54	Inst Own	108.18%	Short Float	6.37%	Perf Quarter	10.42%
Income	81.07M	P/S	8.17	EPS this Y	3.49%	Inst Trans	3.54%	Short Ratio	4.79	Perf Half Y	20.10%
Sales	1.22B	P/B	4.92	EPS next Y	9.91%	ROA	3.12%	Short Interest	9.84M	Perf YTD	7.89%
Book/sh	12.90	P/C	57.42	EPS next 5Y	9.47%	ROE	3.96%	52W High	72.16 -12.07%	Perf Year	-7.16%
Cash/sh	1.10	P/FCF	44.51	EPS past 3/5Y	-34.80% -20.58%	ROIC	3.45%	52W Low	46.01 37.90%	Perf 3Y	-16.83%
Dividend Est.	0.32 (0.50%)	EV/EBITDA	26.70	Sales past 3/5Y	3.33% 10.55%	Gross Margin	66.57%	Volatility	3.15% 4.16%	Perf 5Y	-35.75%
Dividend TTM	0.32 (0.50%)	EV/Sales	8.31	EPS Y/Y TTM	-48.18%	Oper. Margin	22.60%	ATR (14)	2.55	Perf 10Y	204.39%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	3.08	Sales Y/Y TTM	1.64%	Profit Margin	6.67%	RSI (14)	44.50	Recom	1.79
Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	4.54	EPS Q/Q	11.46%	SMA20	-5.31%	Beta	1.47	Target Price	75.25
Payout	69.67%	Debt/Eq	0.17	Sales Q/Q	-0.39%	SMA50	-0.02%	Rel Volume	1.19	Prev Close	64.80
Employees	3100	LT Debt/Eq	0.17	Earnings	Feb 04 BMO	SMA200	11.69%	Avg Volume	2.06M	Price	63.45
IPO	Feb 09, 1989	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.99% 1.86%	Trades		Volume	2,468,290	Change	-2.08%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$73
Aug-21-25	Upgrade	Citigroup	Neutral → Buy	$70
Jul-22-25	Resumed	Stephens	Overweight	$65
Jul-09-25	Initiated	TD Cowen	Buy	$65
May-30-25	Initiated	Wells Fargo	Overweight	$59
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-18-25	Initiated	Evercore ISI	Outperform	$75
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$88 → $68
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600

Show Previous Ratings

Feb-11-26 12:04PM	What Are Wall Street Analysts' Target Price for Bio-Techne Stock? (Barchart)
09:00AM	Bio-Techne Announces Changes to its Leadership Team (PR Newswire)
12:36AM	5 Insightful Analyst Questions From Bio-Techne's Q4 Earnings Call (StockStory)
Feb-06-26 10:22AM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Feb-05-26 12:34AM	TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets (StockStory)
04:01PM	Loading…
Feb-04-26 04:01PM	Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ... (GuruFocus.com) +6.25%
11:22AM	Bio-Techne Q2 Earnings Call Highlights (MarketBeat)
10:38AM	Bio-Techne (TECH) Q2 2026 Earnings Call Transcript (Motley Fool)
09:34AM	TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up (Zacks)
09:30AM	Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:40AM	Techne (TECH) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:37AM	Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales (StockStory)
06:30AM	Bio-Techne Releases Second Quarter Fiscal 2026 Results (PR Newswire)
06:30AM	Bio-Techne Declares Dividend (PR Newswire)
Feb-03-26 08:29AM	MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More (Zacks)
10:04PM	Loading…
Feb-02-26 10:04PM	Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect (StockStory)
06:30AM	Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative (PR Newswire)
Jan-30-26 11:40AM	CSLLY or TECH: Which Is the Better Value Stock Right Now? (Zacks)
08:44AM	Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock? (Zacks)
Jan-28-26 06:30AM	Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers (PR Newswire)
Jan-20-26 07:00AM	Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results (PR Newswire)
Jan-12-26 06:49PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Jan-09-26 08:37AM	Here's What to Expect From Bio-Techne's Next Earnings Report (Barchart)
Jan-05-26 11:05PM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory) +5.67%
Jan-03-26 07:20AM	Klaviyo, Wingstop among Stephens Best Ideas for 2026 (TipRanks)
Dec-30-25 10:34PM	Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) (StockStory)
Dec-23-25 07:00AM	Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference (PR Newswire)
Dec-22-25 09:17AM	Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains? (Zacks)
Dec-16-25 07:40AM	Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector? (Barchart)
Dec-11-25 09:36AM	Here's Why BioTechne (TECH) Traded Lower in Q3 (Insider Monkey)
06:30AM	Loading…
06:30AM	Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology (PR Newswire)
Dec-09-25 06:30AM	Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis (PR Newswire)
Dec-04-25 10:29AM	Bio-Techne Corporation (TECH): A Bull Case Theory (Insider Monkey)
Nov-25-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Nov-18-25 06:30AM	Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio (PR Newswire)
Nov-13-25 11:28PM	Bio-Techne Stock: Is Wall Street Bullish or Bearish? (Barchart)
09:01AM	Is Bio-Techne Corporation (TECH) a High-Quality Growth-Oriented Compounder Within The Healthcare Sector? (Insider Monkey)
Nov-11-25 03:55PM	Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know (StockStory)
Nov-07-25 05:36PM	McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. (Barrons.com)
Nov-06-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Nov-05-25 09:57PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
04:03PM	Bio-Techne Corp (TECH) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
10:52AM	TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up (Zacks)
09:30AM	Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings (Zacks)
07:40AM	Techne (TECH) Meets Q1 Earnings Estimates (Zacks)
06:38AM	Bio-Techne (NASDAQ:TECH) Misses Q3 Revenue Estimates, Stock Drops (StockStory)
06:30AM	Bio-Techne Releases First Quarter Fiscal 2026 Results (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Nov-04-25 09:01AM	AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients (PR Newswire)
Nov-03-25 10:17PM	What To Expect From Bio-Techne's (TECH) Q3 Earnings (StockStory)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Sonoma Biotherapeutics (PR Newswire)
Oct-31-25 03:21PM	Why Bio-Techne (TECH) Stock Is Up Today (StockStory)
Oct-30-25 07:27PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Oct-29-25 10:00AM	Techne (TECH) Reports Next Week: What to Know Ahead of the Release (Zacks)
Oct-28-25 06:30AM	Bio-Techne Launches ProximityScope Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research (PR Newswire)
Oct-23-25 06:56PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:54AM	Bio-Techne Q1 Earnings Preview: What's in Store for the Stock? (Zacks)
07:00AM	ScaleReady Announces multiple G-Rex Grants have been awarded to leading investigators at Children's National Hospital (PR Newswire)
Oct-16-25 12:04AM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory)
Oct-15-25 09:00AM	Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents (Business Wire)
07:00AM	Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results (PR Newswire)
Oct-14-25 11:40AM	GMAB or TECH: Which Is the Better Value Stock Right Now? (Zacks)
08:48AM	Earnings Preview: What to Expect From Bio-Techne's Report (Barchart)
Oct-09-25 07:00AM	Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 (PR Newswire)
Oct-08-25 08:18AM	Should You Continue to Hold Bio-Techne Stock in Your Portfolio? (Zacks)
Oct-03-25 04:16PM	S&P 500 Stocks: These 5 Lead As Index Hits Record High (Investor's Business Daily)
Sep-30-25 04:00PM	Bio-Techne (TECH) Shares Skyrocket, What You Need To Know (StockStory) +6.51% +7.71%
Sep-29-25 08:22AM	Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions (Zacks)
Sep-26-25 06:30AM	Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications (PR Newswire)
Sep-24-25 07:28AM	BioTechne (TECH) Fell Over the Industry's Uncertain Funding Environment (Insider Monkey)
07:15AM	Is Bio-Techne Stock Underperforming the Dow? (Barchart)
06:59AM	Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report (PR Newswire)
Sep-19-25 09:31AM	Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength? (Zacks)
Sep-16-25 11:31PM	Research Tools & Consumables Stocks Q2 Highlights: Bio-Techne (NASDAQ:TECH) (StockStory)
Sep-15-25 09:28AM	Here's Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne's (TECH) Long-Term Growth Profile (Insider Monkey)
Sep-10-25 03:11PM	Why Bio-Techne (TECH) Stock Is Down Today (StockStory) -5.98%
Sep-09-25 04:05PM	CONMED Corporation Adds Kim Kelderman to its Board of Directors (Business Wire)
07:00AM	ScaleReady Awards G-Rex Grants to Support Cell and Gene Therapy Manufacturing in California (PR Newswire)
Sep-02-25 02:26PM	Why Bio-Techne (TECH) Shares Are Sliding Today (StockStory)
Aug-27-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Aug-22-25 03:40PM	Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know (StockStory) +5.72%
Aug-21-25 09:36AM	CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls (The Fly)
Aug-19-25 07:57AM	Bio-Techne Stock: Analyst Estimates & Ratings (Barchart)
Aug-14-25 07:00AM	ScaleReady Announces Award of a G-Rex Grant to the Gates Institute's Translational Sciences Laboratory (PR Newswire)
Aug-13-25 01:35AM	The 5 Most Interesting Analyst Questions From Bio-Techne's Q2 Earnings Call (StockStory)
Aug-12-25 03:17AM	TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty (StockStory) +5.34%
Aug-11-25 02:56PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Aug-06-25 01:20PM	Why Bio-Techne (TECH) Shares Are Plunging Today (StockStory) -8.73%
09:31AM	Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations (StockStory)
09:30AM	Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings (Zacks)
09:05AM	Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls (Zacks)
07:50AM	Techne (TECH) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:30AM	Bio-Techne Releases Fourth Quarter Fiscal 2025 Results (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Aug-05-25 04:30PM	Bio-Techne Announces Exosome Diagnostics Divestiture (PR Newswire)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Sidra Medicine (PR Newswire)
Aug-04-25 11:19PM	Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow (StockStory)
09:51AM	Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? (Zacks)
Aug-01-25 08:13AM	Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending (Insider Monkey)
07:46AM	Bio-Techne Corporation (TECH) Slid on Rise in Investors' Concerns (Insider Monkey)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Herr Amy E.	Director	Feb 03 '26	Option Exercise	0.00	38	0	2,192	Feb 05 06:30 PM
McManus Matthew	President - Diag & Spatial Bio	Feb 01 '26	Option Exercise	0.00	4,621	0	9,356	Feb 03 05:04 PM
Hippel James	CFO	Nov 03 '25	Option Exercise	0.00	24,704	0	154,587	Nov 05 04:46 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Nov 03 '25	Option Exercise	0.00	9,911	0	25,023	Nov 05 04:46 PM
Nusse Roeland	Director	Aug 25 '25	Option Exercise	21.84	17,040	372,154	61,599	Aug 27 04:10 PM
Nusse Roeland	Director	Aug 25 '25	Sale	56.36	17,040	960,388	44,559	Aug 27 04:10 PM
BAUMGARTNER ROBERT V	Director	Aug 25 '25	Option Exercise	21.84	17,040	372,154	61,903	Aug 27 04:09 PM
BAUMGARTNER ROBERT V	Director	Aug 25 '25	Sale	56.21	17,040	957,818	44,863	Aug 27 04:09 PM
ROELAND NUSSE	Director	Aug 25 '25	Proposed Sale	56.36	17,040	960,388		Aug 25 04:05 PM
ROBERT V. BAUMGARTNER4731 BONI	Director	Aug 25 '25	Proposed Sale	56.21	17,040	957,849		Aug 25 04:04 PM
Hippel James	CFO	Aug 15 '25	Option Exercise	0.00	4,010	0	131,809	Aug 19 05:38 PM
Herr Amy E.	Director	Aug 15 '25	Option Exercise	0.00	279	0	2,255	Aug 19 05:29 PM
Kelderman Kim	Chief Executive Officer	Aug 15 '25	Option Exercise	0.00	8,543	0	55,273	Aug 19 05:28 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '25	Option Exercise	0.00	1,718	0	4,912	Aug 19 05:28 PM
McManus Matthew	President - Diag & Spatial Bio	Aug 15 '25	Option Exercise	0.00	2,637	0	5,615	Aug 19 05:28 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Aug 15 '25	Option Exercise	0.00	2,623	0	15,915	Aug 19 05:27 PM
HIGGINS JOHN L	Director	Aug 07 '25	Option Exercise	21.84	5,040	110,074	65,236	Aug 11 07:06 PM
Hippel James	CFO	Jul 29 '25	Option Exercise	44.33	168,620	7,474,925	275,230	Jul 31 04:28 PM
Kelderman Kim	Chief Executive Officer	Jul 22 '25	Option Exercise	44.33	48,176	2,135,642	90,379	Jul 24 04:26 PM
Kelderman Kim	Chief Executive Officer	Jul 15 '25	Option Exercise	44.33	36,132	1,601,732	75,136	Jul 17 05:04 PM
Herr Amy E.	Director	Jun 09 '25	Option Exercise	44.33	1,280	56,742	3,256	Jun 11 04:20 PM
Herr Amy E.	Director	Jun 09 '25	Sale	49.77	1,280	63,705	1,976	Jun 11 04:20 PM
JOSHUA MOLHO	Officer	Jun 09 '25	Proposed Sale	49.77	1,280	63,705		Jun 09 04:19 PM
HIGGINS JOHN L	Director	May 01 '25	Option Exercise	21.84	12,000	262,080	60,196	May 05 04:18 PM
Bohnen Shane	SVP - General Counsel	Apr 03 '25	Option Exercise	0.00	2,260	0	3,941	Apr 07 04:25 PM
Herr Amy E.	Director	Feb 14 '25	Option Exercise	44.33	1,976	87,596	3,836	Feb 18 04:49 PM
Herr Amy E.	Director	Feb 14 '25	Sale	65.96	1,860	122,691	1,976	Feb 18 04:49 PM
JOSHUA MOLHO	Domestic Partner of Director	Feb 14 '25	Proposed Sale	65.96	1,860	122,691		Feb 14 04:08 PM

QSI

Quantum-Si Incorporated

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience